AF
SNDX icon

Allworth Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Allworth Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Sell
1,169
-517
-31% -$10.8K ﹤0.01% 3000
2026
Q1 		$39.4K Buy
1,686
+557
+49% +$12.1K ﹤0.01% 2504
2025
Q4 		$23.7K Buy
1,129
+384
+52% +$6.7K ﹤0.01% 2693
2025
Q3 		$11.5K Buy
745
+505
+210% +$6.61K ﹤0.01% 3061
2025
Q2 		$2.25K Buy
240
+206
+606% +$2.27K ﹤0.01% 3651
2025
Q1 		$453 Sell
34
-125
-79% -$1.76K ﹤0.01% 3706
2024
Q4 		$2.23K Sell
159
-195
-55% -$3.34K ﹤0.01% 3115
2024
Q3 		$6.82K Hold
354
– – ﹤0.01% 2433
2024
Q2 		$8.17K Hold
354
– – ﹤0.01% 2311
2024
Q1 		$8.43K Sell
354
-10
-3% -$223 ﹤0.01% 2177
2023
Q4 		$7.87K Buy
364
+355
+3,944% +$5.46K ﹤0.01% 2083
2023
Q3 		$131 Sell
9
-18
-67% -$340 ﹤0.01% 3295
2023
Q2 		$566 Hold
27
– – ﹤0.01% 2872
2023
Q1 		$571 Sell
27
-39
-59% -$970 ﹤0.01% 2818
2022
Q4 		$1.68K Buy
66
+31
+89% +$723 ﹤0.01% 2303
2022
Q3 		$1K Buy
+35
New +$785 ﹤0.01% 2499

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Allworth Financial's SNDX Position: Q2 2026 in Review

Allworth Financial reduced its Syndax Pharmaceuticals (SNDX) stake by 31% in Q2 2026, selling an estimated $10.8K and leaving 1,169 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

Allworth Financial first reported a position in SNDX in Q3 2022 and has held it in 16 quarters since. The position peaked at $39.4K in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Allworth Financial held 1,169 shares of Syndax Pharmaceuticals worth $25.6K as of Q2 2026.
  • Allworth Financial sold 517 Syndax Pharmaceuticals shares in Q2 2026, an estimated $10.8K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3000 holding.
  • Allworth Financial first reported a position in Syndax Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Allworth Financial's Syndax Pharmaceuticals position peaked at $39.4K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.